Results 301 to 310 of about 1,039,481 (386)

Through the lens of marketing authorization holders: experience in use of real‐world data and real‐world evidence in drug development and regulatory submissions in EU

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this study was to assess the general and product‐specific experiences of MAHs use of RWD/RWE in medicines development and in their regulatory submissions, and to explore organizational aspects of MAHs related to RWD/RWE. Methods An electronic survey was conducted, and information collected directly from MAHs.
Sini M. Eskola, Aleksandar Gigov, Hubertus G. M. Leufkens, Andrew Bate, Marie Louise De Bruin, Helga Gardarsdottir   +5 more
wiley   +1 more source

Political appeals in tobacco marketing: Tucker Carlson unveils Alp nicotine pouch brand on X. [PDF]

Tob Control
Kostygina G, Carter CC, Barari S, Borowiecki M, Emery SL.   +4 more
europepmc   +1 more source

Unstoppable trends: The impact, role, and ideology of Yemeni news websites

, 2008
Walid Al-Saqaf
openalex   +1 more source

Safety concerns reported by coroners following fentanyl patch fatalities in England, Wales and Northern Ireland between 1997 and 2024

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim To identify safety concerns reported by coroners following fentanyl patch‐related deaths in England, Wales and Northern Ireland, and determine differences in coronial reporting. Methods A systematic case series linking the National Programme on Substance Use Mortality (NPSUM) and the Preventable Deaths Tracker (PDT) (https ...
Eman Mshari, Caroline S. Copeland, Georgia C. Richards   +2 more
wiley   +1 more source

Discomfort in the Unexpected: A Mixed-Methods Study on Australian Clinicians' Experiences of Explaining Prenatal Screening Results. [PDF]

Aust N Z J Obstet Gynaecol
Anderson MB, Cooke E, Thorpe K, Chawla JK.   +3 more
europepmc   +1 more source

Celestinesca's new website!

, 2021
openaire   +2 more sources

Increasing the reporting of adverse drug reaction‐related hospitalizations using an ICD‐10‐based identification workflow: A multicentre study from Switzerland

British Journal of Clinical Pharmacology, EarlyView.
Background Reporting adverse drug reactions (ADRs) is essential for drug safety. In Switzerland, healthcare professionals are legally required to report serious and unlabelled ADRs, yet under‐reporting remains widespread. We tested a novel method to increase reporting of ADR‐related hospitalizations.
Georgia Anita Weber, Sophie‐Charlotte Bartel, Michael Boch, Christoph Rosen, Michael Bodmer, Balthasar Luzius Hug, Thomas Stammschulte, Patrick E. Beeler   +7 more
wiley   +1 more source

Implementation of the Korea Disease Control and Prevention Agency Infectious Disease ALERT: Timely Information Sharing to Strengthen Frontline Healthcare Response. [PDF]

Public Health Wkly Rep
Kim H, Jin YW, Lee J, Lee SW, Yoo H.
europepmc   +1 more source

Advanced therapy medicinal products (ATMPs) – An analysis of the global regulatory status

British Journal of Clinical Pharmacology, EarlyView.
Abstract Background A rapid progress in the development of advanced therapy medicinal products (ATMPs) has taken place over the past decades. The ATMPs hold great potential but face challenges in the clinical development and the regulatory process.
Allan Cramer, Freja Karuna Hemmingsen Sørup, Marie Lund, Tonny Studsgaard Petersen, Kristian Karstoft   +4 more
wiley   +1 more source

How did the COVID-19 pandemic reshape exercise-based mobile health in Korea?: A comparative big data analysis. [PDF]

Medicine (Baltimore)
Park SU.
europepmc   +1 more source